Trials / Completed
CompletedNCT02009241
Pulmonary Rehabilitation in Lymphangioleiomyomatosis
Evaluation of the Impact of a Pulmonary Rehabilitation Program on Exercise Capacity in Patients With Lymphangioleiomyomatosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- University of Sao Paulo General Hospital · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Lymphangioleiomyomatosis (LAM) is a rare disease in which reduced exercise capacity is frequently present. The mechanisms applied are airflow obstruction, abnormal diffusion capacity and dynamic hyperinflation (DH). Pulmonary rehabilitation (PR) has proved benefit in improving exercise tolerance, dyspnea, and quality of life in chronic obstructive pulmonary disease. There are no studies evaluating the impact of PR in patients with LAM. The hypothesis under study is that PR determine improvement in exercise capacity, dyspnea, quality of life, muscle force, functional limitation and DH in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pulmonary Rehabilitation |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-04-01
- Completion
- 2015-05-01
- First posted
- 2013-12-11
- Last updated
- 2015-12-11
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02009241. Inclusion in this directory is not an endorsement.